Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters











Database
Publication year range
1.
Life Sci ; 285: 119960, 2021 Nov 15.
Article in English | MEDLINE | ID: mdl-34536495

ABSTRACT

AIMS: Sertraline (SE) is one of the most prescribed medications for treating gestational depression, anxiety and stress. However, little is known about its effects on nervous-system development in offspring. Therefore, this study investigated the somatic, reflex and neurobehavioral development of rats exposed to SE during pregnancy, associated or not with stress. MAIN METHODS: Pregnant Wistar rats were assigned to the following groups (n = 10-8 rats/group): CO - control animals administered filtered water by gavage; SE - animals administered 20 mg/kg SE by gavage; ST - animals subjected to restraining stress and administered filtered water; ST/SE - animals subjected to restraining stress and administered 20 mg/kg SE. The treatment was administered between gestational days (GD) 13 to 20. Somatic and reflex developments were investigated in the male offspring from postnatal day (PND) 1 to 21. The elevated plus maze was performed on PND 25 and 80. The open field and light/dark box test were performed on PND 90 and 100, respectively. KEY FINDINGS: Body weight reduction and vaginal bleeding were observed in pregnant rats exposed to SE. The male offspring of the SE group showed delay in incisor eruption, fur development and negative geotaxis. In addition, the SE group was less exploratory (anxious personality) compared to the CO and ST groups. SIGNIFICANCE: The results obtained in the present study demonstrate that sertraline not only impairs maternal health, but also, associated or not with stress, can compromise the somatic, reflex and neurobehavioral development of male rats.


Subject(s)
Animal Fur/drug effects , Antidepressive Agents/adverse effects , Maternal Exposure/adverse effects , Prenatal Exposure Delayed Effects/chemically induced , Sertraline/adverse effects , Stress, Psychological/drug therapy , Tooth Eruption/drug effects , Uterine Hemorrhage/chemically induced , Animals , Animals, Newborn , Antidepressive Agents/administration & dosage , Female , Incisor/growth & development , Male , Maze Learning/drug effects , Pregnancy , Rats , Rats, Wistar , Reflex/drug effects , Sertraline/administration & dosage , Taxis Response/drug effects , Weight Loss
2.
Prep Biochem Biotechnol ; 51(4): 375-385, 2021.
Article in English | MEDLINE | ID: mdl-32940546

ABSTRACT

Calotropis procera produces a milky sap containing proteolytic enzymes. At low concentrations, they induce milk-clotting (60 µg/ml) and to dehair hides (0.05 and 0.1%). A protocol for obtaining the enzymes is reported. The latex was mixed with distilled water and the mixture was cleaned through centrifugation. It was dialyzed with distilled water and centrifuged again to recover the soluble fraction [EP]. The dialyze is a key feature of the process. EP was characterized in terms of protein profile, chemical stability, among other criteria. Wild plants belonging to ten geographic regions and grown in different ecological conditions were used as latex source. Collections were carried out, spaced at three-month, according to the seasons at the site of the study. Proteolytic activity was measured as an internal marker and for determining stability of the samples. EP was also analyzed for metal content and microbiology. EP showed similar magnitude of proteolysis, chromatographic and electrophoretic profiles of proteins. Samples stored at 25 °C exhibited reduced solubility (11%) and proteolytic capacity (11%) after six months. Enzyme autolysis was negligible. Microbiological and metal analyses revealed standard quality of all the samples tested. EP induced milk clotting and hide dehairing after storage for up to six months.


Subject(s)
Aspartic Acid Endopeptidases/metabolism , Calotropis/enzymology , Chemistry Techniques, Analytical/standards , Ecosystem , Latex/chemistry , Plant Proteins/metabolism , Seasons , Animal Fur/drug effects , Animals , Aspartic Acid Endopeptidases/analysis , Aspartic Acid Endopeptidases/chemistry , Aspartic Acid Endopeptidases/pharmacology , Cattle , Goats , Hair Removal/methods , Latex/isolation & purification , Plant Proteins/analysis , Plant Proteins/chemistry , Plant Proteins/pharmacology , Proteolysis , Reference Standards , Solubility
3.
Article in German | MEDLINE | ID: mdl-32823347

ABSTRACT

OBJECTIVE: A commercially available medication containing homeopathic ingredients showed first signs of success in atopic dermatitis in dogs. The aim of this case series was to evaluate the effect of the preparation in a larger number of dogs with atopic dermatitis. MATERIAL AND METHODS: Ten atopic dogs received the oral homoeopathic combination preparation daily for 3 weeks according to the manufacturer's specifications. The diagnosis of atopic dermatitis was made previously by medical history, clinical examination and exclusion of differential diagnoses. Skin infections with bacteria and yeasts were excluded by clinical examination and cytological evaluation of impression smears. In food-allergic dogs, an elimination diet was fed at least 2 months prior and during the entire study period. Patients with suspected or confirmed flea allergy received flea control for at least 1 month prior to and during the study. The clinical signs were evaluated before and after therapy using a validated Pruritus Visual Analogue Acale (PVAS) and the Canine Atopic Dermatitis Lesion Index (CADLI). The coat quality was assessed by the owners. Possible adverse effects were recorded at the recheck. RESULTS: There were no significant changes in the lesion score (Wilcoxon test, p = 1.0), pruritus score (paired t test, p = 0.34) and coat quality (paired t test, p = 0.34) over the duration of treatment. Only one patient showed a slight improvement in itching and coat quality. No side effects were observed. CONCLUSION AND CLINICAL RELEVANCE: In this case series, the tested homoeopathic preparation did not show a positive effect on the clinical signs of canine atopic dermatitis.


Subject(s)
Dermatitis, Atopic , Dog Diseases/drug therapy , Materia Medica , Animal Fur/drug effects , Animals , Dermatitis, Atopic/drug therapy , Dermatitis, Atopic/veterinary , Dogs , Female , Male , Materia Medica/adverse effects , Materia Medica/pharmacology , Materia Medica/therapeutic use , Pruritus/drug therapy , Pruritus/veterinary
4.
Meat Sci ; 143: 69-73, 2018 Sep.
Article in English | MEDLINE | ID: mdl-29715662

ABSTRACT

"Blown pack" spoilage is primarily caused by Clostridium estertheticum. The primary source of contamination is probably pelts, faeces and soil during opening cuts and de-hiding. Peroxyacetic acid (POAA) based fogs are commonly included in an abattoir's routine cleaning process. Hydrogen peroxide (H2O2) is a powerful oxidizing agent that penetrates microbe cell walls causing cell death. In this study, we compared the ability of H2O2 and OXYSAN ZS (POAA containing 1-hydroxyethylidine-1,1-diphosphonic acid as a stabilizer) in different formats to inactivate C. estertheticum spores. Hydrogen peroxide treatment using Phytagel™ gel as carrier was effective on fleece against both naturally contaminating microflora and C. estertheticum spores. This is the first time an antimicrobial treatment has been shown to inactivate C. estertheticum spores on such a complex and highly contaminated matrix. Both H2O2 and OXYSAN ZS treatments inactivated C. estertheticum spores on stainless steel indicating their potential use as an in-plant decontamination procedure or inclusion in routine in-process cleaning.


Subject(s)
Anti-Bacterial Agents/pharmacology , Clostridium/drug effects , Disinfectants/pharmacology , Hydrogen Peroxide/pharmacology , Peracetic Acid/pharmacology , Spores, Bacterial/drug effects , Abattoirs , Animal Fur/drug effects , Animal Fur/microbiology , Animals , Anti-Bacterial Agents/chemistry , Bacterial Load/drug effects , Clostridium/growth & development , Clostridium/physiology , Disinfectants/chemistry , Food Contamination/prevention & control , Food Microbiology , Gels , Hydrogen Peroxide/chemistry , Meat-Packing Industry/methods , Microbial Viability/drug effects , New Zealand , Peracetic Acid/chemistry , Sheep, Domestic , Spores, Bacterial/growth & development , Spores, Bacterial/physiology , Stainless Steel , Volatilization
5.
Biol Trace Elem Res ; 182(2): 257-264, 2018 Apr.
Article in English | MEDLINE | ID: mdl-28689237

ABSTRACT

The objective of this study was to investigate the effects of different sources and levels of zinc (Zn) on growth performance, nutrient digestibility, serum biochemical parameters, and fur quality in growing-furring male mink. Animals in the control group were fed a basal diet with no Zn supplementation. Mink in the other nine treatments were fed the basal diet supplemented with Zn from either grade Zn sulfate (ZnSO4·7H2O), Zn glycinate (ZnGly), or Zn pectin oligosaccharides (ZnPOS) at concentrations of either 100, 300, or 900 mg Zn/kg dry matter. One hundred and fifty healthy 15-week-old male mink were randomly allocated to ten dietary treatments (n = 15/group) for a 60-day trial from mid-September to pelting in December. Mink in the Zn-POS groups had higher average daily gain than those in the control group (P < 0.05). Zn source slightly improved the feed/gain (P = 0.097). N retention was increased by Zn addition (P < 0.05). Mink supplemented with dietary Zn had higher (P < 0.05) pancreas Zn level than the control group. Fur length was greater (P < 0.05) in ZnGly and ZnPOS groups compared with the control. In addition, fur length and fur density increased (linear, P < 0.05) with Zn supplementation in the diet. In conclusion, our data show that dietary Zn addition improves growth performance by increasing nitrogen retention and fat digestibility in growing-furring mink and Z-POS is equally bioavailable to mink compared to ZnGly.


Subject(s)
Animal Fur/drug effects , Animal Nutritional Physiological Phenomena/drug effects , Body Weight/drug effects , Zinc Compounds/pharmacology , Animal Feed/analysis , Animals , Biological Availability , Dietary Supplements , Glycine/administration & dosage , Glycine/analogs & derivatives , Glycine/pharmacokinetics , Glycine/pharmacology , Male , Mink , Oligosaccharides/administration & dosage , Oligosaccharides/pharmacokinetics , Oligosaccharides/pharmacology , Pectins/administration & dosage , Pectins/pharmacokinetics , Pectins/pharmacology , Random Allocation , Time Factors , Zinc Compounds/administration & dosage , Zinc Compounds/pharmacokinetics
6.
Int J Mol Sci ; 18(10)2017 Oct 18.
Article in English | MEDLINE | ID: mdl-29057820

ABSTRACT

Recombinant human fibroblast growth factor 10 (rhFGF-10) is frequently used to treat patients with skin injuries. It can also promote hair growth. However, the effective application of rhFGF-10 is limited because of its poor stability and transdermal absorption. In this study, polymerase chain reaction (PCR) and Southern blotting were used to identify transgenic safflowers carrying a gene encoding an oleosin-rhFGF-10 fusion protein. The size and structural integrity of oleosin-rhFGF-10 in oil bodies extracted from transgenic safflower seeds was characterized by polyacrylamide gel electrophoresis and western blotting. Oil body extracts containing oleosin-rhFGF-10 were topically applied to mouse skin. The absorption of oleosin-rhFGF-10 was studied by immunohistochemistry. Its efficiency in promoting wound healing and hair regeneration were evaluated in full thickness wounds and hair growth assays. We identified a safflower line that carried the transgene and expressed a 45 kDa oleosin-rhFGF-10 protein. Oil body-bound oleosin-rhFGF-10 was absorbed by the skin with higher efficiency and speed compared with prokaryotically-expressed rhFGF-10. Oleosin-rhFGF-10 also enhanced wound closure and promoted hair growth better than rhFGF-10. The application of oleosin-rhFGF-10 in oil bodies promoted its delivery through the skin, providing a basis for improved therapeutic effects in enhancing wound healing and hair growth.


Subject(s)
Carthamus tinctorius/chemistry , Drug Carriers/chemistry , Fibroblast Growth Factor 10/administration & dosage , Hair Follicle/metabolism , Plant Proteins/chemistry , Wound Healing , Animal Fur/drug effects , Animal Fur/growth & development , Animals , Fibroblast Growth Factor 10/pharmacokinetics , Fibroblast Growth Factor 10/pharmacology , Hair Follicle/drug effects , Humans , Male , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL
SELECTION OF CITATIONS
SEARCH DETAIL